 Antiviral Agents
"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 1 | 1 | 2 | | 1991 | 3 | 0 | 3 | | 1992 | 4 | 0 | 4 | | 1993 | 2 | 2 | 4 | | 1994 | 3 | 2 | 5 | | 1995 | 4 | 0 | 4 | | 1996 | 2 | 0 | 2 | | 1997 | 5 | 2 | 7 | | 1998 | 5 | 1 | 6 | | 1999 | 5 | 0 | 5 | | 2000 | 4 | 1 | 5 | | 2001 | 4 | 1 | 5 | | 2002 | 9 | 4 | 13 | | 2003 | 7 | 1 | 8 | | 2004 | 10 | 4 | 14 | | 2005 | 6 | 4 | 10 | | 2006 | 6 | 3 | 9 | | 2007 | 11 | 7 | 18 | | 2008 | 11 | 3 | 14 | | 2009 | 10 | 5 | 15 | | 2010 | 13 | 5 | 18 | | 2011 | 11 | 9 | 20 | | 2012 | 9 | 4 | 13 | | 2013 | 15 | 3 | 18 | | 2014 | 9 | 3 | 12 | | 2015 | 19 | 9 | 28 | | 2016 | 22 | 6 | 28 | | 2017 | 12 | 5 | 17 | | 2018 | 8 | 0 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Murray KF, Balistreri WF, Bansal S, Whitworth S, Evans HM, Gonzalez-Peralta RP, Wen J, Massetto B, Kersey K, Shao J, Garrison KL, Parhy B, Brainard DM, Arnon R, Gillis LA, Jonas MM, Lin CH, Narkewicz MR, Schwarz K, Rosenthal P. Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11. Hepatology. 2018 12; 68(6):2158-2166.
-
Shah DD, Singh SM, Mallela KMG. Effect of Chemical Oxidation on the Higher Order Structure, Stability, Aggregation, and Biological Function of Interferon Alpha-2a: Role of Local Structural Changes Detected by 2D NMR. Pharm Res. 2018 Oct 15; 35(12):232.
-
Tyler KL. Acute Viral Encephalitis. N Engl J Med. 2018 Aug 09; 379(6):557-566.
-
Kane M, Rebensburg SV, Takata MA, Zang TM, Yamashita M, Kvaratskhelia M, Bieniasz PD. Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2. Elife. 2018 08 07; 7.
-
Trang TP, Whalen M, Hilts-Horeczko A, Doernberg SB, Liu C. Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature. Transpl Infect Dis. 2018 Apr; 20(2):e12844.
-
Seifert SM, Castillo-Mancilla JR, Erlandson K, Morrow M, Gandhi M, Kuncze K, Horng H, Zheng JH, Bushman LR, Kiser JJ, MaWhinney S, Anderson PL. Brief Report: Adherence Biomarker Measurements in Older and Younger HIV-Infected Adults Receiving Tenofovir-Based Therapy. J Acquir Immune Defic Syndr. 2018 03 01; 77(3):295-298.
-
Gall B, Pryke K, Abraham J, Mizuno N, Botto S, Sali TM, Broeckel R, Haese N, Nilsen A, Placzek A, Morrison T, Heise M, Streblow D, DeFilippis V. Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway. J Virol. 2018 03 15; 92(6).
-
Romanucci V, Agarwal C, Agarwal R, Pannecouque C, Iuliano M, De Tommaso G, Caruso T, Di Fabio G, Zarrelli A. Silibinin phosphodiester glyco-conjugates: Synthesis, redox behaviour and biological investigations. Bioorg Chem. 2018 04; 77:349-359.
-
Kriss M, Burchill M. HCV and nonhepatic malignancy: Is pre-emptive direct-acting antiviral therapy indicated prior to treatment? Hepatology. 2018 01; 67(1):4-6.
-
Meyerson NR, Zhou L, Guo YR, Zhao C, Tao YJ, Krug RM, Sawyer SL. Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation. Cell Host Microbe. 2017 Nov 08; 22(5):627-638.e7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|